MIGS Device
iSTAR Medical MIGS Device Studies: Highly Promising in Glaucoma Patients
The two-year final outcomes from STAR-I trial and six-month results from its European trial STAR-II have been accepted for presentation at the European Glaucoma Society meeting, now postponed to December 2020 following the Covid-19 pandemic.
